Metraipolis › archive › dc_567e402f5bb6

Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with… — Europe PMC PMID:41302127

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41302127
DOI
10.3390/life15111703
License (as archived)
solo-consultazione
Archived
2026-11-08T20:03:05.524Z
SHA-256 of the archived text
cd68fa80e6093e1e3d5282377905c154c22dd760223cbcce70d6025fada6acfa
Stable URL of this page
https://metraipolis.com/documento/dc_567e402f5bb6

How to cite

Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with… — Europe PMC PMID:41302127 — Europe PMC (en), https://europepmc.org/article/MED/41302127 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_567e402f5bb6 (Metraipolis archive dc_567e402f5bb6, sha256 cd68fa80e6093e1e3d5282377905c154c22dd760223cbcce70d6025fada6acfa)
BibTeX
@misc{dc567e402f5bb6,
  title = {Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with… — Europe PMC PMID:41302127},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41302127},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_567e402f5bb6; sha256 cd68fa80e6093e1e3d5282377905c154c22dd760223cbcce70d6025fada6acfa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41302127. Agents can read the archived copy with the MCP tool read_document.